Menu
ncarol.com
  • Home
  • Health
  • Real Estate
  • Business
  • Non-profit
  • Transportation
  • Education
  • Technology
  • Beauty
ncarol.com

Electroshock and Antidepressants: Hidden Dangers in Misdiagnosed Holiday Blues
ncarol.com/10281885

Trending...
  • Kaltra Offers Microchannel Condensers Optimized for Low-GWP Refrigerants R454B, R32, and R290
  • $114.6 Million in Revenues, Up 54%: Uni-Fuels Holdings (N A S D A Q: UFG) Accelerates Global Expansion Across Major Shipping Hubs as Demand Surges
  • UK Financial Ltd Confirms All 8 Mexican Gold Mines Exist — Audited and Backing UKFL's Ecosystem With Double the 2018 Gold Value
ECT and Antidepressants: Hidden Dangers
A new study reveals widespread misinformation about electroshock therapy among patients. CCHR says parents are similarly misled about ECT use on teens and children as young as five. Moreover, antidepressants—often a precursor to ECT recommendations—also carry significant risks.

LOS ANGELES - ncarol.com -- A new study reveals that patients feel misinformed about the risks of electroconvulsive therapy (ECT), reinforcing the argument that the practice should be banned, according to mental health industry watchdog, Citizens Commission on Human Rights International. Study participants shared accounts of immediate cognitive and memory impairments, as well as long-term effects such as profound loss of abilities, memory, humanity, and personal connections, along with psychological harm and a sense of brain damage. Published in Qualitative Health Research, the study highlights that many patients are denied recognition of their adverse outcomes, which intensifies their struggles.[1]

CCHR says that in the U.S., young teens and children under six have undergone ECT. Lacking the ability to consent, parents—often misinformed about its safety and efficacy—agree to the practice. They are likely unaware that no clinical trials have substantiated safety and efficacy.

The information leaflets provided to patients regarding ECT have been found to minimize the prevalence or severity of memory loss, researchers found. The study says, "Following ECT, there is a possibility of permanent adverse effects including memory and cognitive impairment" and that "Iatrogenic harm, the infliction of harm through medical interventions, is a known possible outcome of ECT."

While the survey of consumers occurred in the United Kingdom, CCHR says that similar patient complaints about ECT have been reported to the group in the U.S. and other countries. Recently, CCHR International supported groups helping a Minnesota man who was threatened with court-ordered ECT when he refused to consent to it. The man had already received 17 courses of involuntary shock and was terrified of undergoing more.

More on ncarol.com
  • UV Weathering Test Chamber vs Xenon Arc Test Chamber: What's the Right Solution for Your Products
  • Emeritus Addresses Hospital Bed Shortages with Smart Storage Solutions
  • Fulton County & Grow Your World Amplify Atlanta Youth Through the Youth Audio Collective
  • 2026 Oscars Betting Odds: One Battle After Another Favored for Best Picture
  • Allen Field Co., Inc. Components Selected for Esko ArtiosCAD 3D Component Library

In its letter to the psychiatric hospital attempting to force ECT upon the 44-year-old man, CCHR cited numerous United Nations reports that say involuntary, forced electroshock constitutes torture and that U.S. courts have acknowledged ECT's risks to patients, including brain damage, memory loss, and cognitive disability.[2]

ECT is often recommended when other treatments have not worked, especially antidepressants. These drugs also have iatrogenic side effects. The UK's Medicines and Healthcare Products Regulatory Agency (MHRA) is currently reviewing safety alerts for 30 antidepressants, after Thomas Kingston, husband of Lady Gabriella Kingston, daughter of Prince and Princess Michael of Kent, fatally shot himself due to adverse effects from these drugs.[3] A coroner ruled Mr. Kingston shot himself due to the adverse effect of the medications he had been prescribed, which included the common antidepressant citalopram. According to evidence given at his inquest, Mr. Kingston had complained that another antidepressant was making him anxious. A medical expert at the inquest, Dr David Healy, suggested this was a sign that SSRI antidepressants "did not suit him" and that he should not have been prescribed citalopram following this. "We need a much more explicit statement saying that these drugs can cause people to commit suicide who wouldn't have otherwise," he said.[4]

MHRA data shows 71 alerts since 2014 over deaths linked to citalopram and 114 for sertraline.[5]

According to JAMA Psychiatry, ECT is recommended after two antidepressants have failed as "first-line" treatments. CCHR says consumers are often misinformed and, therefore, are unaware that treatment side effects can drive them to have suicidal feelings. When these increase, they are further misled into believing it is their mental state "at fault," rather than the adverse mental and physical effects synonymous with both antidepressants and electroshock.

More on ncarol.com
  • The International Window Coverings Expo Returns to Raleigh, NC April 21–23, 2026
  • Thirteen Reasons Why Gyminny Kids Is San Diego's Best Gymnastics Gym
  • Make Holiday Travel Easier with Carbon Fiber Belts from NoNickel
  • Heritage At Manalapan - A New Luxury Single Family Home Community Coming Late 2025
  • North Carolina Constitutional Economist Earns 4-Star Book Review from Literary Titan

During the holiday season, CCHR is committed to raising awareness about individuals experiencing sorrow because of a lost one, loneliness, being away from family, and more. People can become unwitting candidates for having such emotions misdiagnosed as "holiday depression," and put at risk of being prescribed antidepressants. CCHR wants to see different, non-invasive approaches taken to help individuals and strongly urges against agreeing to electroshock therapy, recommending legal support if necessary to prevent it from being forced on any individual.

Founded 55 years ago by the Church of Scientology and psychiatrist Dr. Thomas Szasz, CCHR has achieved significant milestones in mental health reform. In 1976, it played a pivotal role in securing the first-ever prohibition on electroshocking minors in California. Similarly, in 2014, CCHR helped enact legislation in Western Australia that made administering ECT to minors a criminal offense. The organization was also instrumental in prompting the Food and Drug Administration to hold hearings on the potential suicidal effects of SSRI antidepressants, leading to the FDA issuing warnings of suicidal ideation for individuals under 24.
Sources:

[1] Emily Shipwright, David Murphy, "Long-Term Adverse Effects After Electroconvulsive Therapy (ECT): A Narrative Analysis Exploring People's Experiences, Meaning-Making, and Coping," Qualitative Health Research, 2024, journals.sagepub.com/doi/10.1177/10497323241303391

[2] "CCHR Supports Minnesota Man's Opposition to Enforced Electroshock Treatment," CCHR International, 4 Dec. 2024, www.cchrint.org/2024/12/04/cchr-supports-opposition-to-enforced-electroshock-treatment/

[3] "More than 100 alerts over deaths linked to antidepressants taken by Thomas Kingston," The Independent, 8 Dec. 2024, www.independent.co.uk/news/health/antidepressant-citalopram-thomas-kingston-b2658665.html

[4] "More than 100 alerts over deaths linked to antidepressants taken by Thomas Kingston," The Independent, 8 Dec. 2024, www.independent.co.uk/news/health/antidepressant-citalopram-thomas-kingston-b2658665.html

[5] "More than 100 alerts over deaths linked to antidepressants taken by Thomas Kingston," The Independent, 8 Dec. 2024, www.independent.co.uk/news/health/antidepressant-citalopram-thomas-kingston-b2658665.html

Contact
CCHR International
***@cchr.org


Source: Citizens Commission on Human Rights
Filed Under: Health

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Webinar Announcement: Reputational Risk Management in Internal Investigations: Controlling the Narrative Before, During, and After a Crisis
  • Taking on the Multi-Billion-Dollar Swipe Industry: AI Curates Who You Meet—IRL over brunch
  • BillyGoat Mulching Introduces Advanced Subsoil Mulching for Premium Land Finishing and Development
  • 5,000 Australians Call for Clarity: NaturismRE's Petition Reaches Major Milestone
  • Cartwheel Signs Letter of Intent to License Clearsight Therapeutics' Novel Pink Eye Treatment for 2027 Portfolio Expansion
  • Vet Maps Launches National Platform to Spotlight Veteran-Owned Businesses and Causes
  • $114.6 Million in Revenues, Up 54%: Uni-Fuels Holdings (N A S D A Q: UFG) Accelerates Global Expansion Across Major Shipping Hubs as Demand Surges
  • Dental Care Solutions Unveils New Website for Enhanced Patient Engagement
  • TradingHabits.com Launches to Support Day Trader Well-being
  • $750 Million Market on Track to $3.35 Billion by 2034: $NRXP Launches First-in-Florida "One Day" Depression Treatment in Partnership with Ampa Health
  • $750 Million Market Set to Soar to $3.35 Billion by 2034 as Florida Launches First-in-Nation One-Day: NRx Pharmaceuticals (N A S D A Q: NRXP) $NRXP
  • BITE Data raises $3m to build AI tools for global trade compliance teams
  • Phinge Issues Notice of Possible Infringement, Investigates App-less AI Agents & Technology for Unauthorized Use of its Patented App-less Technologies
  • Huntington Learning Center of Russellville Marks 1 Year Anniversary; Extends Reduced Grant-Aligned Rates to All Students in Learning Center Services
  • CCHR Supports Call to End Coercive Psychiatry at World Mental Health Congress
  • purelyIV Expands Wellness Services with Flu/COVID Testing and Menopause Coaching & Treatment
  • Perfume Making Kit: Professional Fragrance Creation Gift
  • WHES Retains BloombergNEF Tier 1 Ranking for Sixth Consecutive Quarter
  • U.S. Entrepreneur Anjo De Heus Builds Innovation Bridge Between America and the Gulf
  • UK Financial Ltd Confirms All 8 Mexican Gold Mines Exist — Audited and Backing UKFL's Ecosystem With Double the 2018 Gold Value
_catLbl0 _catLbl1

Popular on ncarol.com

  • J French's #1 Album "I Don't Believe in Bad Days" Enters the Grammy Conversation - 164
  • Heritage at South Brunswick's Townhome Models Coming Soon! - 151
  • Arc Longevity Sells Out Debut Women's Creatine Gummy - 148
  • $300 Million Web3 Initiative and ZIGChain Partnership Power $20 Target in Noble Capital Markets Report for SEGG Media (N A S D A Q: SEGG) - 140
  • Preston Dermatology & Skin Surgery Center and Dr. Sheel Desai Solomon Dominate Raleigh's Best Awards from The News & Observer - 138
  • $430 Million 2026 Revenue Forecast; 26% Organic Growth; $500,000 Stock Dividend Highlight a Powerful AI & Digital Transformation Story: IQSTEL $IQST - 136
  • Mysterious Interstellar Object 3I/ATLAS Appears to Pause Near Mars, Exhibiting Periodic Light Pulses - 135
  • Mature Athlete - Want Elite, Web-Based Nutrition and Training Coaching? - 134
  • Maisano Brothers Inc. Expands National Paving Division Into Tampa, Florida - 129
  • New Free Educational Bingo Cards Make Learning English Fun for First Graders - 128

Similar on ncarol.com

  • Emeritus Addresses Hospital Bed Shortages with Smart Storage Solutions
  • Fulton County & Grow Your World Amplify Atlanta Youth Through the Youth Audio Collective
  • Heritage At Manalapan - A New Luxury Single Family Home Community Coming Late 2025
  • The Lashe® Announces Exclusive November Savings for Lash and Beauty Professionals
  • November is Lung Cancer Awareness Month: Screening Saves Aims to Increase Access to Lung Screenings in NC
  • Valeo Health Leads a New Era of Longevity and Preventive Health in the UAE
  • 5,000 Australians Call for Clarity: NaturismRE's Petition Reaches Major Milestone
  • Cartwheel Signs Letter of Intent to License Clearsight Therapeutics' Novel Pink Eye Treatment for 2027 Portfolio Expansion
  • Dental Care Solutions Unveils New Website for Enhanced Patient Engagement
  • TradingHabits.com Launches to Support Day Trader Well-being
Copyright © 2025 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute